share_log

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Benzinga Real-time News ·  Jan 12, 2023 08:08

Gainers

  • Yield10 Bioscience (NASDAQ:YTEN) stock increased by 68.1% to $3.53 during Thursday's pre-market session. The company's market cap stands at $17.4 million.
  • Eyenovia (NASDAQ:EYEN) shares increased by 15.42% to $2.17. The market value of their outstanding shares is at $78.3 million.
  • Acer Therapeutics (NASDAQ:ACER) shares increased by 14.03% to $3.25. The market value of their outstanding shares is at $64.0 million.
  • TC BioPharm (Holdings) (NASDAQ:TCBP) stock rose 13.5% to $4.54. The company's market cap stands at $180.4 million.
  • ASLAN Pharma (NASDAQ:ASLN) stock rose 12.39% to $0.68. The market value of their outstanding shares is at $47.4 million.
  • BeyondSpring (NASDAQ:BYSI) shares increased by 10.23% to $2.37. The market value of their outstanding shares is at $92.2 million.

Losers

  • Oramed Pharmaceuticals (NASDAQ:ORMP) stock decreased by 73.1% to $2.9 during Thursday's pre-market session. The company's market cap stands at $113.4 million.
  • Biora Therapeutics (NASDAQ:BIOR) shares declined by 15.38% to $5.67. The company's market cap stands at $50.6 million.
  • NuCana (NASDAQ:NCNA) shares declined by 14.39% to $1.25. The market value of their outstanding shares is at $65.2 million.
  • DarioHealth (NASDAQ:DRIO) shares declined by 10.58% to $4.65. The company's market cap stands at $119.4 million.
  • Fresh Tracks Therapeutics (NASDAQ:FRTX) stock fell 10.33% to $1.65. The market value of their outstanding shares is at $4.9 million.
  • Oncternal Therapeutics (NASDAQ:ONCT) shares declined by 10.32% to $1.13. The market value of their outstanding shares is at $63.6 million. See Also:

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment